
Last update at 2026-06-09T17:47:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2025 Financial Results
Thu 01 May 25, 10:00 AMOaktree Specialty Lending: 13% Yield, Hidden Quality
Fri 18 Apr 25, 11:28 AMQ1 2025 Oaktree Specialty Lending Corp Earnings Call
Wed 05 Feb 25, 07:54 AMOaktree Specialty Lending (OCSL) Q1 Earnings Match Estimates
Tue 04 Feb 25, 12:20 PMOaktree Specialty Lending Corporation Announces First Fiscal Quarter 2025 Financial Results
Tue 04 Feb 25, 11:00 AM| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | 119.06M | 32.86M | 240.84M | 37.45M | 127.17M |
| Minority interest | - | - | - | - | - |
| Net income | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Selling general administrative | 11.66M | 9.25M | 9.07M | 7.12M | 7.95M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 125.20M | 39.11M | 248.31M | 52.31M | 127.13M |
| Reconciled depreciation | - | - | - | - | - |
| Ebit | 180.78M | 79.79M | 240.84M | 37.45M | 127.17M |
| Ebitda | 180.78M | 216.04M | 126.32M | 37.45M | 127.17M |
| Depreciation and amortization | -292.33900M | 136.25M | -114.51900M | -98.28100M | -100.33500M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 180.78M | 79.79M | 240.84M | 37.45M | 127.17M |
| Other operating expenses | 9.77M | 6.25M | 7.46M | 14.86M | 0.04M |
| Interest expense | 111.64M | 46.93M | 30.52M | 26.29M | 32.43M |
| Tax provision | 1.73M | 3.64M | 2.79M | -1.77000M | 1.01M |
| Interest income | 368.53M | 249.44M | 190.83M | 133.43M | 139.17M |
| Net interest income | 256.89M | 202.51M | 160.31M | 107.14M | 106.74M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 1.73M | 3.64M | 3.58M | -1.77000M | 1.01M |
| Total revenue | 125.20M | 39.11M | 248.31M | 52.31M | 127.13M |
| Total operating expenses | 6.14M | 6.25M | 7.46M | 14.86M | -0.04300M |
| Cost of revenue | -223.56100M | 55.66M | 71.40M | 39.26M | 50.32M |
| Total other income expense net | -61.71000M | -46.92900M | -30.51800M | -26.28900M | -32.42600M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Net income applicable to common shares | - | 29.22M | 237.26M | 39.22M | 126.16M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Total assets | 3217.84M | 2646.31M | 2636.39M | 1640.71M | 1481.04M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 9.62M | -29.33400M | 0.22M | 0.49M |
| Total liab | 1702.08M | 1400.75M | 1323.56M | 725.83M | 550.41M |
| Total stockholder equity | 1515.76M | 1245.56M | 1312.82M | 914.88M | 930.63M |
| Deferred long term liab | - | 7.38M | 9.31M | 6.01M | 6.40M |
| Other current liab | -18.95700M | -11.63700M | -7.62100M | -2.69800M | -3.88500M |
| Common stock | 0.77M | 1.83M | 1.80M | 1.41M | 1.41M |
| Capital stock | 0.77M | 1.83M | 1.80M | 1.41M | 1.41M |
| Retained earnings | -651.33800M | -582.76900M | -493.33500M | -574.30400M | -558.55300M |
| Other liab | - | - | 2.11M | - | 0.70M |
| Good will | - | - | - | - | - |
| Other assets | 139.49M | 13.57M | 14.61M | 8.76M | 8.73M |
| Cash | 136.45M | 23.53M | 29.33M | 39.10M | 15.41M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 18.96M | 11.64M | 7.62M | 2.70M | 3.88M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 1464.28M | 1277.52M | 1239.41M | 670.22M | 457.96M |
| Short term debt | - | 601.04M | 638.74M | - | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 1600.73M | 1301.04M | 1268.74M | 709.32M | 473.37M |
| Other stockholder equity | 2166.33M | 1826.50M | 1804.35M | 1487.77M | 1487.77M |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 181.02M | 131.84M | 63.24M | 57.88M | 33.77M |
| Long term investments | 2897.33M | 2500.90M | 2558.54M | 1574.07M | 1438.53M |
| Net tangible assets | - | 1245.56M | 1312.82M | 914.88M | 930.63M |
| Short term investments | -4.91000M | 214.16M | - | - | - |
| Net receivables | 160.59M | 108.31M | 33.91M | 18.78M | 18.37M |
| Long term debt | - | - | - | - | 158.54M |
| Inventory | - | - | - | - | - |
| Accounts payable | 18.96M | 11.64M | 7.62M | 2.70M | 3.88M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 1.41M | 1.41M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -2897.33000M | -1.68700M | -0.71400M | -0.84700M | -1438.53200M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2897.33M | 2500.90M | 2558.54M | 1574.07M | 1438.53M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | 158.54M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Investments | - | - | - | - | - |
| Change to liabilities | - | 0.68M | -0.42600M | -0.51700M | -1.99200M |
| Total cashflows from investing activities | - | - | - | - | - |
| Net borrowings | - | 70.00M | 315.10M | 236.21M | -157.65900M |
| Total cash from financing activities | -110.41400M | -26.81500M | 224.19M | 176.33M | -214.10700M |
| Change to operating activities | - | -55.97000M | 30.12M | -63.51100M | 44.13M |
| Net income | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Change in cash | 119.17M | -5.27100M | -7.46100M | 23.69M | 1.92M |
| Begin period cash flow | 26.36M | 31.64M | 39.10M | 15.41M | 13.49M |
| End period cash flow | 145.54M | 26.36M | 31.64M | 39.10M | 15.41M |
| Total cash from operating activities | 228.76M | 22.39M | -230.52100M | -152.87500M | 215.82M |
| Issuance of capital stock | 1.37M | 20.84M | 0.00000M | 0.00000M | - |
| Depreciation | 28.55M | 136.25M | -114.51900M | 20.61M | -38.45700M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | 180.05M | 115.25M | 79.85M | 53.10M | 52.22M |
| Change to inventory | -73.52000M | 33.16M | 4.62M | 0.41M | -21.27900M |
| Change to account receivables | -33.88100M | -16.11500M | -8.49500M | 4.23M | 21.28M |
| Sale purchase of stock | -2.41800M | -1.85700M | -2.17000M | -1.87800M | -1.34400M |
| Other cashflows from financing activities | 857.68M | 299.45M | 842.96M | 576.68M | 294.60M |
| Change to netincome | - | 60.16M | -493.70600M | -134.79200M | 45.84M |
| Capital expenditures | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -107.40100M | -71.40800M | 21.20M | -59.79600M | 41.24M |
| Stock based compensation | 53.12M | - | 114.39M | -19.06300M | 38.17M |
| Other non cash items | 135.49M | -70.69500M | -488.98300M | -132.30300M | 48.42M |
| Free cash flow | 228.76M | 22.39M | -230.52100M | -152.87500M | 215.82M |
Sector: Financial Services Industry: Credit Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | ||
|---|---|---|---|---|---|---|---|---|
| OCSL Oaktree Specialty Lending Corp |
0.03 0.25% | 11.90 | 14.14 | 10.26 | 3.82 | 1.01 | ||
| V Visa Inc. Class A |
4.41 1.38% | 324.07 | 31.25 | 25.97 | 16.18 | 13.64 | 16.19 | 23.37 |
| MA Mastercard Inc |
7.34 1.51% | 493.01 | 37.04 | 29.50 | 16.14 | 62.35 | 16.47 | 27.24 |
| AXP American Express Company |
5.79 1.85% | 318.09 | 21.46 | 18.83 | 3.38 | 6.76 | 3.93 | |
| COF Capital One Financial Corporation |
1.53 0.85% | 181.92 | 61.36 | 10.04 | 3.84 | 1.12 | 3.02 |
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
333 South Grand Avenue, Los Angeles, CA, United States, 90071
| Name | Title | Year Born |
|---|---|---|
| Mr. Armen Panossian J.D. | CEO & Chief Investment Officer | 1977 |
| Mr. Mathew M. Pendo | Pres | 1964 |
| Mr. Aman Kumar | Managing Director & Co-Portfolio Mang. of Life Sciences Direct Lending | NA |
| Mr. Raghav Khanna | Managing Director & Co-Portfolio Mang. | 1984 |
| Mr. Chris McKown | MD, CFO & Treasurer | 1982 |
| Mr. Matthew Stewart C.F.A., CPA, CFA, CPA | Sr. VP & COO | 1985 |
| Mr. Emil O. Caliboso | Accounting Supervisor | NA |
| Mr. Michael Mosticchio | Investor Relations | NA |
| Ms. Ashley Pak | Chief Compliance Officer | 1978 |
| Mr. Sandeep Kumar Khorana | Managing Director of Origination | 1973 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.